Details
Stereochemistry | ACHIRAL |
Molecular Formula | Pb.S |
Molecular Weight | 239.3 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[S--].[PbH2++]
InChI
InChIKey=DDCACOMLHWHRLN-UHFFFAOYSA-N
InChI=1S/Pb.S.2H/q+2;-2;;
Molecular Formula | Pb |
Molecular Weight | 207.2 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | HS |
Molecular Weight | 33.073 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/27486358http://nj.gov/health/eoh/rtkweb/documents/fs/1107.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/2535340FRITZ BISCHOFF, L. C. MAXWELL, RICHARD D. EVANS, and FRANKLIN R. NUZUM. Journal of Pharmacology and Experimental Therapeutics September 1928, 34 (1) 85-109, retrived from http://jpet.aspetjournals.org/content/34/1/85 | https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/20340530 | https://www.ncbi.nlm.nih.gov/pubmed/18935555Curator's Comment: description was created based on several sources, including
https://ntp.niehs.nih.gov/ntp/newhomeroc/roc11/lead-public_508.pdf
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27486358http://nj.gov/health/eoh/rtkweb/documents/fs/1107.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/2535340FRITZ BISCHOFF, L. C. MAXWELL, RICHARD D. EVANS, and FRANKLIN R. NUZUM. Journal of Pharmacology and Experimental Therapeutics September 1928, 34 (1) 85-109, retrived from http://jpet.aspetjournals.org/content/34/1/85 | https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/20340530 | https://www.ncbi.nlm.nih.gov/pubmed/18935555
Curator's Comment: description was created based on several sources, including
https://ntp.niehs.nih.gov/ntp/newhomeroc/roc11/lead-public_508.pdf
There is no information about biological application only a few articles about pharmacological application of lead fluoride, that this substance was investigated for topical dental caries.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Microbial uptake of lead. | 1972 Jun 23 |
|
Interaction of lead and bacterial lipids. | 1975 May |
|
Abiotic factors affecting the toxicity of lead to fungi. | 1979 Sep |
|
Mutagenic effects of lead (II) bromide. | 1989 Dec |
|
[The late effects of exposure to lead fluoride]. | 1992 Mar |
|
Structural Chemistry of Poly(ethylene glycol) Complexes of Lead(II) Nitrate and Lead(II) Bromide. | 1996 Nov 20 |
|
[Lead in the blood and protoporphyrin levels in erythrocytes in glass workers exposed to lead]. | 1997 Dec |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27486358
It was investigated the cytotoxicity of lead chloride in vitro cultured lymphocytes from human umbilical cord blood, using four monitoring methods namely, trypan blue staining, acridine orange/ethidium bromide staining, 3-[4,5-dimethylthiazol-2-yl] 2,5-diphenyl tetrazolium bromide (MTT) and neutral red uptake assays; lead genotoxicity to lymphocytes was monitored by comet assay. The MIC value in each method was invariably 300 mg/L for PbCl2. Lethal concentration25 (LC25) values were almost in an agreeable range: 691.83 to 831.76 mg/L; LC50 values in each method were almost in the range: 1174.9 to 1348.9 mg/L; LC100 values were in the range: 3000 to 3300 mg/L, for lead chloride. The comet assay also indicated that the LC100 values were 3300 mg/L lead chloride. Thus, both cytotoxicity and genotoxicity were recorded at 3300 mg/L lead chloride with lymphocytes.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:47:38 GMT 2023
by
admin
on
Fri Dec 15 17:47:38 GMT 2023
|
Record UNII |
2425D15SYM
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
215-246-6
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY | |||
|
2425D15SYM
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY | |||
|
C018391
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY | |||
|
1314-87-0
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY | |||
|
DTXSID0025498
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY | |||
|
m6746
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY | Merck Index | ||
|
LEAD(II) SULFIDE
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY | |||
|
300000024312
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY | |||
|
2425D15SYM
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY | |||
|
639
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY | |||
|
1549104
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY | RxNorm | ||
|
9794739
Created by
admin on Fri Dec 15 17:47:38 GMT 2023 , Edited by admin on Fri Dec 15 17:47:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |